Form 4: Ocular Therapeutix CFO Donald Notman Sells Shares to Cover Tax Obligations

Donald Notman, CFO and COO of Ocular Therapeutix, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Donald Notman, the CFO and COO of Ocular Therapeutix, sold shares of the company's common stock on January 31, 2025, and February 4, 2025.
• These sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• On January 31, 2025, 6,301 shares were sold at a weighted average price of $7.84, with prices ranging from $7.68 to $7.97.
• On February 4, 2025, 11,119 shares were sold at a weighted average price of $7.81, with prices ranging from $7.73 to $7.88.
• Following these transactions, Notman directly owns 193,444 shares of Ocular Therapeutix common stock.
• The sales were conducted automatically under a pre-arranged sales instruction letter and do not represent discretionary trades by Notman.
• Notman also acquired 1,876 shares of common stock under the 2014 Employee Stock Purchase Plan on December 31, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports stock sales for tax purposes, which is a common occurrence. The Employee Stock Purchase Plan purchase is a slightly positive sign.

Positives

• Notman's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.

Industry Context

Sales of shares to cover tax obligations are a routine part of executive compensation and are not necessarily indicative of a negative outlook on the company.

Stakeholder Impact

• The stock sales could have a minor, temporary impact on the stock price.

Key Dates

Keywords

Ocular Therapeutix, OCUL, Donald Notman, Form 4, insider trading, stock sale, restricted stock units, tax withholding, Employee Stock Purchase Plan